<DOC>
	<DOCNO>NCT02000297</DOCNO>
	<brief_summary>This study conduct determine whether new synthetic bone substitute well allogenic bone graft address bone defect medial open wedge high tibial osteotomy term postoperative pain , postoperative bleeding , operation time bone healing . The investigator hypothesize new synthetic bone substitute would bring good outcome outcome variable mention .</brief_summary>
	<brief_title>Outcome Comparison Allograft Synthetic Bone Substitute High Tibial Osteotomy</brief_title>
	<detailed_description>High tibial osteotomy well-established treatment option young patient ( age 40~55years ) knee osteoarthritis confine medial compartment knee . Classical technique lateral closing wedge osteotomy , recently medial open wedge osteotomy gain popularity advent new fixation device refine surgical technique . The surgeon correct deformity precisely coronal sagittal plane simultaneously medial opening technique . And avoid complication associate lateral closing technique like tibial shaft offset peroneal nerve palsy . But medial opening technique inevitably create large bone defect , address avoid complication like loss correction delayed/non-union . Autologous bone widely accept standard fill bone defect , supply limit harvest autologous bone add surgical morbidity like bleeding , pain fracture donor site . Therefore , much effort find material substitute autologous bone . Many study report result use allogenic bone address bone defect show favorable result . But allogenic bone product cumbersome process make fit defect , potential risk disease transmission , product properly treat . Bone cement several different composition develop use fill bone defect , also show good result general . Recently , new synthetic bone substitute base calcium phosphate calcium sulfate ( geneX® , Biocomposites Co. , Ltd . ) introduce commercially available . While provide initial mechanical strength , calcium sulfate component rapidly absorb provide space new bone ingrowth surface make negatively charge , help accelerate new bone formation . It provide injectable paste , easy handle allogenic bone , may help reduce operation time . With theoretical advantage , anecdotal report patient treat geneX® present less postoperative pain bleeding patient treat allogenic bone graft . Therefore , conduct study determine whether new synthetic bone substitute ( geneX® ) good allogenic bone address bone defect create medial open wedge high tibial osteotomy .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Diagnosis primary osteoarthritis knee confine medial compartment Scheduled high tibial osteotomy Written sign consent available Patients refuse participate study Previous history major orthopedic surgery around operate knee Congenital anomaly involve proximal tibia Revision high tibial osteotomy Patients receive another major knee surgery simultaneously high tibial osteotomy knee</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>High tibial osteotomy</keyword>
	<keyword>Calcium phosphate</keyword>
	<keyword>Calcium sulfate</keyword>
</DOC>